Safe group announces its 2021 results and recalls its 2022 objectives – 05/02/2022 at 08:45


Éragny-sur-Oise, France, May 2, 2022 at 8:45 a.m. CET – Safe (FR0013467123 – ALSAF), a group specializing in the design, manufacture and marketing of ready-to-use technologies for orthopedic surgeries, particularly for surgery of the back, today announces its 2021 results and recalls its 2022 strategic objectives.
Safe group’s 2021 Annual Financial Report will be available on the Company’s website (www.SafeOrthopaedics.com) under Investors > Documentation > Regulated information from April 30, 2022.

Consolidated Financial Statements – In thousands of euros – IFRS standards 31/12/2021 31/12/2020 21/20 31/12/2019 21/19
Direct sales 1,775 1,647 +8% 2,109 -16%
Indirect sales 990 1,623 -39% 2,683 -63%
Sale of production subcontracting 1,791,415 +332% –
Total turnover 4,556 3,685 +24% 4,792 -5%
Purchases consumed and change in inventory (1,985) (2,259) +12% (3,420) +42%
Gross margin rate 56% 39% +18% 29% +28%
External charges (2,561) (2,081) -23% (3,257) +21%
Personnel costs (6,693) (5,443) -23% (4,633) -44%
Other operating expenses (966) (569) -70% (939) -3%
Current operating income (7,650) (6,667) -15% (7,456) -3%
Other operating income and expenses 85 1 8
Operating income (7,566) (6,666) -13% (7,449) -1%
Financial result 875 -1,640 -521
Net income (6,691) (8,306) +19% (7,970) +16%



Source link -86